PMV Pharmaceuticals Investor Webinar to Review Phase 2 PYNNACLE Interim Data Evaluating Rezatapopt in Patients with Advanced Solid Tumors
| DATE: | September 10, 2025 |
|---|---|
| TIME: | 8:00 AM EDT |
| LOCATION: | Virtual |
About The Event
Join PMV Pharmaceuticals for an investor webinar to review the interim PYNNACLE Phase 2 data and provide a regulatory update. The event will feature presentations by PMV management and Ramez N. Eskander, M.D., Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego.
A live Q&A session will follow the formal presentations.